**Burlington BioCenter Acquired by Owner-User, Reportedly Northeastern University**
Newmark has arranged the sale of the Burlington BioCenter, a premier life science facility located in Burlington, Massachusetts. The 109,085-square-foot property was sold to an undisclosed owner-user, though multiple published reports indicate the buyer was Northeastern University.
The seller, MetLife Investment Management, originally acquired the property in 2022 for $103 million.
The transaction was led by Newmark’s U.S. Capital Markets co-head Robert Griffin, along with Executive Vice Chairman Edward Maher, Vice Chairman Matthew Pullen, Executive Managing Director James Tribble, Senior Managing Director Samantha Hallowell, and Associate Director William Sleeper. Financial analysis support was provided by Grady Zink.
“Burlington BioCenter stands alone in the Burlington submarket for its turnkey laboratory infrastructure and modern, full-floor buildouts,” commented Pullen. “In a region where many life science buildings remain in shell condition, this asset is truly differentiated by its cutting-edge systems and immediate occupancy potential.”
The state-of-the-art facility was originally completed in 2019, with laboratory interiors finalized in 2022. It features high-performance laboratory infrastructure designed to meet the needs of today’s advanced life science users.
